Full-time · England, United Kingdom
Exscientia is an AI-driven pharmatech company committed to discovering, designing and developing the best possible drugs in the fastest and most effective manner. Exscientia developed the first-ever functional precision oncology platform to successfully guide treatment selection and improve patient outcomes in a prospective interventional clinical study, as well as to progress AI-designed small molecules into the clinical setting.
Our pipeline demonstrates our ability to rapidly translate scientific concepts into precision-designed therapeutic candidates, with more than 15 projects underway. By designing better drugs, faster, we believe the best ideas of science can rapidly become the best medicines for patients.
As the Head of Structural Biology you will have the opportunity to lead a high-performing team and drive the growth of our structure-based design capabilities across drug discovery portfolios. Working at the intersection of experimental structural biology, drug design, AI, physics, and informatics, you will be responsible for building technical solutions that increase the quality and efficiency of our design capability.
Please note this is a UK-based hybrid role and regular travel is required to our offices in Oxford, UK (approximately 2-3 days per week), with flexibility to work from home the remaining time. We are a flexible working organisation and we’re willing to consider other options which would provide similar contact time with the team.
Open roles at Exscientia